Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 7,844 | 7,723 | 5,740 | 3,897 | 4,073 |
| Operating Income | -7,844 | -7,723 | -5,740 | -3,897 | -4,073 |
| Interest Expense | 8 | 3 | -1 | 0 | 1 |
| Other Income | -3 | 6 | 500 | 0 | 11 |
| Pre-tax Income | -7,855 | -7,720 | -5,239 | -3,897 | -4,063 |
| Net Income Continuous | -7,855 | -7,720 | -5,239 | -3,897 | -4,063 |
| Net Income | $-7,855 | $-7,720 | $-5,239 | $-3,897 | $-4,063 |
| EPS Basic Total Ops | -0.66 | -0.65 | -0.46 | -0.37 | 7.15 |
| EPS Basic Continuous Ops | -0.67 | -0.65 | -0.46 | -0.37 | 7.16 |
| EPS Diluted Total Ops | -0.66 | -0.65 | -0.46 | -0.37 | 7.15 |
| EPS Diluted Continuous Ops | -0.67 | -0.65 | -0.46 | -0.37 | 7.16 |
| EBITDA(a) | $-7,726 | $-7,437 | $-5,565 | $-3,721 | $-3,817 |